Work

Novel Bispecific Degrader BHV-1300 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models Including Nonhuman Primates (S43.004)

Year: 2024

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000206715

Authors: Anna Bunin, Seong Lee, Wes Kazmierski, Kathleen McGrath, Anne Marie Rossi, Simone Nicholson, Gene Dubowchik, Elizabeth Dierks, Neal Sharpe, David Pirman, Bruce Car, Irfan Qureshi, Vladimir Coric, David Spiegel

Institutions: Biohaven Pharmaceuticals (United States), Yale University

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4394598752

FWCI: 0.509

Cites:

Cited by: 2

Related to: 10